ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
General Health & Fitness
Health & Wellness
Geographic concentration of pharmaceutical manufacturing: The US relies heavily on India
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="Nelson Vergel" data-source="post: 224224" data-attributes="member: 3"><p>The USP Medicine Supply Map analysis (Chart I) counts the number of active API DMFs by location.</p><p></p><p>India accounts for 48%</p><p>China accounts for 13%</p><p>U.S. accounts for 10%</p><p></p><p></p><p>India contributed 62% of active API DMFs filed in 2021, up from 20% filed in 2000. This increase is consistent with the country’s well-publicized national ambition to enhance API manufacturing capabilities.</p><p>Europe’s contribution declined from 49% of active API DMFs filed in 2000 to 7% filed in 2021</p><p>China contributed 18% of new API DMFs filed in 2019, and 23% filed in 2021</p><p>U.S. contributed 4% of new API DMFs filed in 2019 and 2021</p><p></p><p>[ATTACH=full]21915[/ATTACH]</p><p></p><p>Source: <a href="https://qualitymatters.usp.org/geographic-concentration-pharmaceutical-manufacturing" target="_blank">Geographic concentration of pharmaceutical manufacturing: USP Medicine Supply Map analysis | Quality Matters | U.S. Pharmacopeia Blog</a></p></blockquote><p></p>
[QUOTE="Nelson Vergel, post: 224224, member: 3"] The USP Medicine Supply Map analysis (Chart I) counts the number of active API DMFs by location. India accounts for 48% China accounts for 13% U.S. accounts for 10% India contributed 62% of active API DMFs filed in 2021, up from 20% filed in 2000. This increase is consistent with the country’s well-publicized national ambition to enhance API manufacturing capabilities. Europe’s contribution declined from 49% of active API DMFs filed in 2000 to 7% filed in 2021 China contributed 18% of new API DMFs filed in 2019, and 23% filed in 2021 U.S. contributed 4% of new API DMFs filed in 2019 and 2021 [ATTACH type="full" alt="chemical exports from different countries.jpg"]21915[/ATTACH] Source: [URL='https://qualitymatters.usp.org/geographic-concentration-pharmaceutical-manufacturing']Geographic concentration of pharmaceutical manufacturing: USP Medicine Supply Map analysis | Quality Matters | U.S. Pharmacopeia Blog[/URL] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
General Health & Fitness
Health & Wellness
Geographic concentration of pharmaceutical manufacturing: The US relies heavily on India
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top